Eleonora Gaetani and Team Map Global Prevalence of HHT Using Population Genomics
Gemelli Computational Biology and Bioinformatics Lab shared on LinkedIn:
”In a new study published by Journal of Thrombosis and Haemostasis (JTH), we applied a computational, population-scale genomics approach to re-estimate the genetic prevalence of Hereditary Hemorrhagic Telangiectasia (HHT).
We have systematically analyzed known and potentially (according to HHT-specific ACMG/AMP criteria) pathogenic variants in ENG and ACVRL1 across three large genomic resources (gnomAD, All of Us, and Regeneron Genetics Center–Million Exome) and found that the genetic prevalence of HHT is substantially higher than current clinical estimates, thereby highlighting how large-scale variant aggregation and standardized pathogenicity frameworks can uncover underrecognized rare disease burden.
Work by Eleonora Gaetani, Agnese Giovannetti, Luigi Di Martino, Niccolò Liorni, Viviana Caputo, Antonio Gasbarrini, Roberto Pola, Tommaso Mazza at Agostino Gemelli University Hospital Foundation IRCCS”
Title: Global Prevalence of Hereditary Hemorrhagic Telangiectasia-Associated Variants Estimated by Analysis of Large-Scale Genomic Databases
Authors: Eleonora Gaetani, Agnese Giovannetti, Luigi Di Martino, Niccolò Liorni, Viviana Caputo, Antonio Gasbarrini, Roberto Pola, Tommaso Mazza
Read the Full Article on Journal of Thrombosis and Haemostasis (JTH)
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge